The first thought to cross many American’s minds when coming to terms with a chronic illness isn’t whether they will live, but whether they – and their families – can financially survive.
In addition to lacking universal healthcare, the U.S. also has prescription drug prices that are on average 2.56 times higher than other countries around the world. That number increases to 3.44 when dealing with name brands, according to a study by RAND, a nonpartisan, nonprofit research organization.
“Brand-name drugs are the primary driver of the higher prescription drug prices in the United States,” said Andrew Mulcahy, lead author of the study and a senior health policy researcher at RAND, in a news release. “We found consistently high U.S. brand name prices regardless of our methodological decisions.”
While the health care discussion has dominated U.S. airwaves for years, the issue has become even more hotly debated during COVID-19 times.
The health crisis has not only disrupted insurance coverages, provider coverages, and public health, but has also brought to the forefront the racial and ethnic disparities that exist in the U.S. health care system.
Even prior to the global pandemic, U.S. healthcare spending reached $3.6 trillion in 2018, with 14% of that devoted to the purchase of prescription drugs.
A Cheaper Way
Biotech companies, such as EQRx, meanwhile, are researching ways to create and sell pharmaceutical drugs at lower costs, making them more affordable for everyday Americans.
EQRx announced earlier this year that it had raised $500 million in Series B financing, increasing its total funding to $750 million.
Denne historien er fra May 2021-utgaven av The BOSS Magazine.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra May 2021-utgaven av The BOSS Magazine.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Travel Well in 2025
The best places to see & best things to do in the new year
Getting Back to giving
How to revive charitable donations, with Charitybuzz CEO Ben Erwin
Breathtaking BUILDINGS
THE WORLD'S MOST AWE-INSPIRING EDIFICES
ALong for the Ride
Clean energy projects go up in areas once dominated by fossil fuels
HEALTHCARE ANALYTICS: FIGHTING THE GOOD FIGHT
Advanced analytics are transforming healthcare operations and patient care. Nevada's Renown Health is leading the way, creating a roadmap for swift and effective change.
THE RIGHT ACCELERANT
THE POSSIBILITIES - AND LIMITATIONS OF AI IN SCIENTIFIC RESEARCH
IN GLOBAL LOGISTICS
How thinking global and acting local is enlarging the global footprint of the Staci Group
THE RIGHT STUFF
Why veterans thrive in logistics
LIVING MACHINES
BIOHYBRIDS BRING THE POWER OF NATURE TO ROBOTICS
MANUFACTURING'S NEW LOOK
The industry’s reputation doesn’t match reality, but the future is bright